Article
Investigating MATN3 and ASPN as novel drivers of gastric cancer progression via EMT pathways
20 Sept 2024
Abstract excerpt
Gastric cancer (GC) is a leading cause of cancer-related deaths globally, necessitating the identification of novel therapeutic targets. This study investigates the roles of MATN3 and ASPN in GC progression via the epithelial-mesenchymal transition (EMT) pathway. Analysis of the Cancer Genome Atlas-Stomach Adenocarcinoma (TCGA-STAD) dataset revealed that both MATN3 and ASPN are significantly upregulated in GC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
